Judicialização da compra de medicamentos no Brasil entre 2006 e 2015: impactos orçamentários

Abstract

The objective of this study is to analyze how the judicialization of health affects the budgetary appropriations of the governments, specifically identifying the impact on the policy of purchase of medicines in the governmental management of the Union between the years of 2006 and 2015. The budgetary data extracted from the Coordination of (CDJU) and information from the Legal Counsel of the Ministry of Health (CONJUR / MS) allow us to conclude that there was an increase in the judicial demand for drug supplies of around 1040% in the period, and that 95% the study found that there is a diversion of financial resources from MS health programs to thousands of SUS patients at the municipal, state and federal levels to meet individual requests. In addition, the data indicate that more than 65% of the actions in the courts for the request for inputs are cases of medicines not registered by the National Health Surveillance Agency - ANVISA, due to the fact that, in most cases, patients are in search for new and successful research for more resistant and highly complex treatments.